Rajendra Desai
Cardiovascular Disease · Terre Haute, INNPI 1346356920
Payments from drug & device makers
Across 312 payments — averaging $13.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$901
- E.r. Squibb & Sons, L.L.C.$474
- Novartis$459
- Boston Scientific$312
- Sanofi-aventis U.S. LLC$285
- Amgen$263
- plus $2K from 20 others
What the payments were for
- Food & beverage$4,22499%
- Education$401%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 113 | $901 |
| E.r. Squibb & Sons, L.L.C. | 42 | $474 |
| Novartis | 26 | $459 |
| Boston Scientific | 16 | $312 |
| Sanofi-aventis U.S. LLC | 18 | $285 |
| Amgen | 15 | $263 |
| Edwards Lifesciences | 2 | $236 |
| Bayer | 3 | $160 |
| Amarin Pharma, Inc. | 10 | $145 |
| Boehringer Ingelheim | 9 | $144 |
| Pfizer | 11 | $143 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 12 | $136 |
| AstraZeneca | 9 | $125 |
| Merck | 6 | $87 |
| Chiesi USA, Inc. | 3 | $66 |
| Novo Nordisk | 3 | $57 |
| Medtronic(2 entities) | 3 | $52 |
| Lundbeck LLC | 2 | $38 |
| Regeneron Healthcare Solutions, Inc. | 2 | $35 |
| Acist Medical Systems, Inc. | 1 | $28 |
| Akcea Therapeutics, Inc. | 1 | $27 |
| Abbott | 1 | $26 |
| Teleflex LLC | 1 | $20 |
| Shockwave Medical, Inc | 1 | $20 |
| Astellas Pharma US Inc | 1 | $13 |
| Gilead | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,264 in reported general payments places this provider in the 55th percentile of 408 cardiovascular disease providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 130 | $140,707 |
| Repatha SureclickEvolocumab | 74 | $59,875 |
| XareltoRivaroxaban | 47 | $58,679 |
| EntrestoSacubitril/Valsartan | 31 | $34,375 |
| BrilintaTicagrelor | 23 | $18,678 |
| JardianceEmpagliflozin | 13 | $17,301 |
| Nifedipine ErNifedipine | 118 | $3,531 |
| Metoprolol Succinate | 182 | $2,081 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 118 | $1,566 |
| Atorvastatin Calcium | 177 | $1,406 |
| ClopidogrelClopidogrel Bisulfate | 94 | $1,159 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 54 | $921 |
| Carvedilol | 120 | $796 |
| Losartan Potassium | 72 | $712 |
| Pravastatin Sodium | 32 | $704 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $143 | $140,707130 claims |
| Johnson & JohnsonXarelto | $901 | $58,67947 claims |
| NovartisEntresto | $459 | $34,37531 claims |
| AstraZenecaBrilinta | $125 | $18,67823 claims |
| Boehringer IngelheimJardiance | $144 | $17,30113 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 408 cardiovascular disease providers in Indiana.
Other cardiovascular disease in Terre Haute
- Krishna NamburiTerre Haute$73K
- Tony NasserTerre Haute$52K
- John McGintyRichmond$3.7M
- Steven SteinhublLafayette$2.4M
- Ravi BhagwatMunster$2.2M
- Mohan KesaniMunster$1.2M
- Vijay MehtaElkhart$925K
- William CollisFort Wayne$842K
- Atul ChughIndianapolis$775K
- Noel DasguptaIndianapolis$744K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.